80mg (10mg/10mg/50mg/10mg)
Buy 3+ for $147.24 each and save 5%
Buy 5+ for $139.49 each and save 10%
Buy 10+ for $131.74 each and save 15%
This product is for research purposes only. Not for human consumption.
Purity: ≥99% (HPLC verified), supplier-listed specification; confirm component-resolved results for the supplied lot
Formulation: Lyophilized powder blend
Vial: 3 mL vial; 80 mg total labeled content: BPC-157 10 mg, TB-500 10 mg, GHK-Cu 50 mg, KPV 10 mg
Molecular Formula: C62H98N16O22 + C212H350N56O78S + C14H24N6O4Cu + C19H35N5O5
Molecular Weight: 1419.5 + 4963 + 403.9 + 413.5 g/mol
CAS Number: 137525-51-0 / 77591-33-4 / 49557-75-7 / 65189-71-1
PubChem CID: 9941957 / 16132341 / 3014738 / 5497159
Certificate of Analysis: Request component identity, amounts, and lot-specific analytical results; see COA Documents page
BPC-157 + TB-500 + GHK-Cu + KPV-10 KLOW Blend
Overview
The BPC-157 + TB-500 + GHK-Cu + KPV-10 Blend is a formulation containing four peptides in a single lyophilized vial. The components include BPC-157, a fragment of Thymosin Beta-4 (TB-500), GHK-Cu, and KPV (Lys-Pro-Val). Each peptide has been studied for its distinct mechanism of action. BPC-157 has been associated with angiogenesis and cytoprotection in research models. TB-500 is involved in cellular migration. GHK-Cu is reported to influence extracellular matrix synthesis and gene expression. KPV is the C-terminal tripeptide of α-MSH and has been investigated for its properties related to inflammation.
This blend contains a total of 80mg of material (BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, KPV 10mg) and is intended for laboratory research investigating processes such as inflammation, cell migration, and extracellular matrix biology. KPV has attracted research attention for its observed modulation of NF-κB signaling in certain models.
By combining four peptides into one formulation, researchers can study multiple molecular pathways without managing separate materials, which may support more reproducible experimental conditions.
Mechanism of Action
The four peptides in this blend are associated with distinct molecular pathways involved in cellular processes such as inflammation, cellular recruitment, and extracellular matrix synthesis.
No unified mechanism or single receptor has been established here for KLOW blend. Mechanistic interpretation should distinguish individual-component findings from responses measured after exposure to the four-component mixture.
BPC-157 Research Pathways
BPC-157 is a 15-amino-acid research peptide. Rat tendon explant and fibroblast experiments have associated it with outgrowth, migration, and FAK–paxillin phosphorylation. These downstream observations do not establish a direct receptor target or the behavior of this blend.
TB-500 Identity and Evidence Boundaries
Full-length thymosin beta-4 has been investigated in cell migration and experimental wound models. Those results cannot be automatically assigned to a TB-500 fragment; sequence, molecular mass, and modifications must first be matched.
Until the TB-500 form is documented, avoid using full-length thymosin beta-4 studies to claim a proven mechanism for the supplied material. A trade name alone is insufficient evidence of molecular equivalence.
GHK-Cu and KPV Pathways
GHK-Cu is a copper-coordinated Gly-His-Lys complex, distinct from copper-free GHK. Fibroblast studies have examined collagen synthesis after exposure to the complex. Copper coordination, chemical form, and assay medium may affect interpretation.
KPV (Lys-Pro-Val) is the C-terminal tripeptide of α-melanocyte-stimulating hormone. Dalmasso et al. reported PepT1-mediated uptake and reduced NF-κB and MAP kinase inflammatory signaling in experimental cells, alongside findings in mouse colitis models.
Interpreting Mixture Responses
PepT1 is a peptide transporter, not evidence that the entire blend shares one receptor or uptake mechanism. Different component potencies and molecular weights also mean that the labeled mass ratio is not a molar or biological-activity ratio.
Research Findings
Published nonclinical literature relevant to this material’s molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.
BPC-157: Chang et al. (2011) reported increased tendon-fibroblast outgrowth and migration in rat-derived experimental systems, with FAK and paxillin phosphorylation. The study did not test this four-component product or establish healing outcomes in people.
GHK-Cu and KPV: Maquart et al. (1988) observed stimulated collagen synthesis in fibroblast cultures exposed to GHK-Cu. Dalmasso et al. (2008) studied KPV in human-derived cell lines and chemically induced mouse colitis. Human-derived cells are not a human clinical trial.
Full-length thymosin beta-4 context: Malinda et al. (1999) reported wound-related effects in rats and keratinocyte migration assays. This is background evidence only while the TB-500 sequence remains unresolved. None of these constituent studies demonstrates clinical efficacy, safety, or synergy of KLOW blend.
Research Applications
- In vitro angiogenesis assays
- Cell migration studies
- Extracellular matrix biology
- Gene expression analysis
- Inflammation and cytokine signaling
- NF-κB pathway studies
- Musculoskeletal tissue models
- Gastrointestinal mucosal models
- Antimicrobial activity assays
Laboratory Handling & Limitations
This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.
Laboratory Handling
Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.
Storage
Store the lyophilized KLOW blend according to the supplier's product-specific storage instructions and the lot-matched Certificate of Analysis. Protect from moisture and light. Do not assume a storage temperature or reconstituted solution shelf life based on individual components. Confirm blend-specific stability and handling requirements before use.
Research Limitations
Component studies cannot show which constituent causes an observed blend response. Include vehicle and suitable individual-component controls where feasible. Verify analytical identity and quantities separately; a single chromatographic purity percentage does not establish each component's content.
Frequently Asked Questions
What is in the 80 mg KLOW blend?
What should I check before buying KLOW blend online?
What does the ≥99% purity specification establish?
Is TB-500 identical to full-length thymosin beta-4?
Does constituent research prove that this blend works?
Research Use Only
This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.
Scientific References
- Chang, C. H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. Rat-derived explant and cell research.
- Dalmasso, G., et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. Cell and mouse research.
- Maquart, F. X., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. GHK-Cu cell research.
- Malinda, K. M., et al. (1999). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology. Full-length thymosin beta-4 background; not evidence for an unidentified TB-500 fragment or KLOW blend.
Scientific References
Research Use Only
This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.